Selaru, P <br/><br/>
Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib.  [electronic resource] 

 -  Clinical and translational science  Apr 2016 
 - 63-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1752-8062 
<br/><br/><label>Standard No.: </label>10.1111/cts.12388  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Crizotinib<br/>Drug Approval<br/>Drug Discovery<br/>Humans<br/>Neoplasms--drug therapy<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Treatment Outcome